Summary: A new study of male guppies reveals behaviors affected by methylphenidate hydrochloride (MPH), an active ingredient in common ADHD medications, can be passed along to future generations.
Source: University of Toronto
By studying guppies, scientists at the University of Toronto and Florida State University found that behaviors affected by methylphenidate hydrochloride (MPH) – the active ingredient in stimulants such as Ritalin and Concerta used to treat ADHD—can be passed along to several generations of descendants.
“We exposed male and female Trinidadian guppies to a low, steady dose of MPH and saw that it affected the anxiety and stress-related behavior of males, but not females,” said Alex De Serrano, a Ph.D. candidate in the department of ecology and evolutionary biology (EEB) in the Faculty of Arts & Science and lead author of a study published recently in Scientific Reports.
“Because of this male-specific effect, we investigated the effects of MPH through the paternal line and observed the same behaviors in several generations of their descendants not directly administered the drug.”
The findings add to growing knowledge about paternal effects on offspring, as well as the capacity for those effects to span multiple generations—of which even less is known.
From one month of age and through adolescence and into adulthood, first-generation guppies were exposed to MPH via the water in which they lived. The researchers then compared their behavior against a control population exposed to non-treated water and observed that the males exposed to Ritalin were less cautious when placed in a new environment, compared to those not treated with the drug.
“The Ritalin-treated males showed less inhibition than expected when moved to a new environment,” said De Serrano. “Under natural conditions, guppies would be expected to freeze if they found themselves in such a situation, as this allows them to assess their new surroundings for predators and other threats.”
De Serrano then produced three generations of offspring from these individuals to see if the behavior of their descendants differed from descendants of those not exposed to the drug and observed behaviors similar to those of first-generation males exposed to the drug.
“It suggests that Ritalin has the potential to cause changes that persist across several generations,” De Serrano said.
The researchers say the paternal effect of behavioral change may be transmitted to descendants via non-genetic modifications to the sperm of male ancestors exposed to Ritalin. Such molecular changes that don’t affect DNA are a potential mechanism for males to transmit information about their environment—including exposure to drugs or pollutants—to future offspring.
“In many species, including guppies, males do not interact with offspring beyond contributing sperm, so it was traditionally thought that paternal effects would be limited to species where fathers provide some type of care to offspring or other resources to mothers,” said Helen Rodd, a professor in the department of ecology and evolutionary biology who is De Serrano’s supervisor.
“As of now, most known examples in animals of paternal effects and transgenerational effects—effects that span several generations—come from rodents, so our findings add to the handful of studies that have found paternal, transgenerational effects in other species, though the actual mechanism remains unclear.”
It has been suggested that Ritalin could cause transgenerational effects because MPH has been shown to affect the sperm cells of male rodents. Further, paternal effects have been observed in descendants of rats exposed to drugs with a similar mode of action. Despite these concerns, the transgenerational effects of paternal exposure to MPH in humans are unknown.
“I was surprised to learn that no studies had investigated whether a drug so commonly prescribed to adolescent boys to treat ADHD affects the behavior of their offspring,” said De Serrano.
“Because reduced caution in new situations has been associated with increased drug-seeking behavior in rodents and humans, our results suggest that long-term exposure to Ritalin could increase the propensity for drug abuse and other affective disorders in males and their descendants.”
However, the researchers note that, as with all comparative studies, their results only hint at general processes that might be occurring in humans and are not directly translatable to human populations.
“More research is required to determine the mechanism that caused this altered behavior to persist across generations,” said De Serrano. “And in order to extend these results to humans, longitudinal studies following individuals taking Ritalin and their offspring are needed.”
About this epigenetics research news
Source: University of Toronto Contact: Press Office – University of Toronto Image: The image is in the public domain
Paternal exposure to a common pharmaceutical (Ritalin) has transgenerational effects on the behavior of Trinidadian guppies
Evidence is emerging that paternal effects, the nongenetic influence of fathers on their offspring, can be transgenerational, spanning several generations. Methylphenidate hydrochloride (MPH; e.g. Ritalin) is a dopaminergic drug that is highly prescribed to adolescent males for the treatment of Attention-deficit/hyperactivity disorder.
It has been suggested that MPH could cause transgenerational effects because MPH can affect the male germline in rodents and because paternal effects have been observed in individuals taking similar drugs (e.g. cocaine).
Despite these concerns, the transgenerational effects of paternal MPH exposure are unknown. Therefore, we exposed male and female Trinidadian guppies (Poecilia reticulata) to a low, chronic dose of MPH and observed that MPH affected the anxiety/exploratory behaviour of males, but not females. Because of this male-specific effect, we investigated the transgenerational effects of MPH through the paternal line.
We observed behavioural effects of paternal MPH exposure on offspring and great-grandoffspring that were not directly administered the drug, making this the first study to demonstrate that paternal MPH exposure can affect descendants.
These effects were not due to differential mortality or fecundity between control and MPH lines. These results highlight the transgenerational potential of MPH.